- Home
- AVTX vs GCMG Comparison
AVTX vs GCMG Comparison
Compare AVTX & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVTX | GCMG |
|---|---|---|
| Founded | 2011 | 1971 |
| Country | United States | United States |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 805.6M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AVTX | GCMG |
|---|---|---|
| Price | $12.14 | $12.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $44.08 | $15.50 |
| AVG Volume (30 Days) | ★ 959.1K | 439.2K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 3.67% |
| EPS Growth | 72.07 | ★ 1300.00 |
| EPS | N/A | ★ 0.17 |
| Revenue | $27,813,137.00 | ★ $557,565,000.00 |
| Revenue This Year | N/A | $5.87 |
| Revenue Next Year | N/A | $14.24 |
| P/E Ratio | ★ N/A | $76.94 |
| Revenue Growth | ★ 2312.27 | 8.47 |
| 52 Week Low | $12.51 | $9.30 |
| 52 Week High | $24.27 | $14.87 |
Technical Indicators
Market Signals| Indicator | AVTX | GCMG |
|---|---|---|
| Relative Strength Index (RSI) | 22.50 | 43.87 |
| Support Level | N/A | $12.40 |
| Resistance Level | $20.54 | $13.41 |
| Average True Range (ATR) | 0.84 | 0.36 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 1.24 | 40.82 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG, and absolute return strategies. The company invests maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.